A client who is taking dextroamphetamine-amphetamine extended-release tablets for attention deficit hyperactivity disorder (ADHD), reports about having difficulty sleeping at night. Which assessment is most important for the nurse to obtain?

A. Determine daily caffeine intake: Caffeine can impact sleep, but the primary concern with dextroamphetamine-amphetamine extended-release tablets is their potential to cause insomnia as a side effect. Assessing caffeine intake is secondary but can be considered if other factors are ruled out. B. Ask about the client's bedtime routine: The bedtime routine may affect sleep quality, but it is less directly related to the medication's effects compared to the timing of the medication. This information is useful but not as crucial in this context. C. Determine what time the dose is taken: The timing of dextroamphetamine-amphetamine administration is crucial because taking the medication too late in the day can interfere with sleep. This medication is known to cause insomnia if taken too close to bedtime, so assessing the timing is most important to address the sleep difficulty. D. Inquire about perceived anxiety: Anxiety can affect sleep, but the primary issue with dextroamphetamine-amphetamine extended-release tablets is their known side effect of causing insomnia. Addressing the timing of the medication is more directly related to resolving sleep issues in this case.